Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Clinico-Morphological Profile and Receptor Status in Breast Cancer Patients in a South Indian Institution

  • Published : 2014.10.11
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Breast cancer is the most common malignancy in women worldwide and the second most common cancer in females in India. Receptor status may be important for survival. Objective: To analyse and correlate the clinical and morphological parameters with receptor status in breast carcinoma patients in a tertiary care institution in Southern India. Materials and Methods: This retrospective study involved 320 patients of breast cancer diagnosed in an oncology hospital over a period of $3^{1/2}$ years. Data was analysed using SPSS Version 21. Results: Some 60.6% patients with breast carcinomas belonged to the age group of 40 to 60 years. The most common histological type was infiltrating ductal carcinoma, not otherwise specified, accounting for 84.4% of patients. On immunohistochemistry, estrogen receptor (ER) and progesterone receptor (PR) were expressed in 56.3% and 53.1% of cases, respectively. Conclusions: Breast cancers in India, a developing country, occur in younger women and tend to be more aggressive with lower rates of ER and PR expression and higher histological tumor grades. Both ER and PR status of the tumors had significant associations with the patient age, pathological TNM stage and histological tumor grade.

Keywords

References

  1. Ambroise M, Ghosh M, Mallikarjuna VS, Kurian A (2011). Immunohistochemical profile of breast cancer patients at a tertiary care hospital in South India. Asian Pac J Cancer Prev, 12, 625-9.
  2. Breast. In: Edge SB, Byrd DR, Compton CC, et al (2010), eds.: AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer, 347-76.
  3. Elston CW, Ellis IO (1991). Pathological prognostic factors in breast cancer. The value of histological grade in breast cancer: experience from large study with long-term followup. Histopathology, 19, 403-10. https://doi.org/10.1111/j.1365-2559.1991.tb00229.x
  4. Li CY, Zhang S, Zhang XB, et al (2014). Clinicopathological and prognostic characteristics of triple-negative breast cancer (TNBC) in Chinese patients: A retrospective study. Asian Pac J Cancer Prev, 14, 3779-84. https://doi.org/10.7314/APJCP.2013.14.6.3779
  5. Ma KK, Chau WW, Wong CHN, et al (2013). Triple negative status is a poor prognostic indicator in Chinese women with breast cancer: a ten year review. Asian Pac J Cancer Prev, 13, 2109-14. https://doi.org/10.7314/APJCP.2012.13.5.2109
  6. Murthy NS, Chaudhry K, Nadayil D, Agarwal UK, Saxena S (2009). Changing trends in incidence of breast cancer: Indian scenario. Indian J Cancer, 46, 73-4. https://doi.org/10.4103/0019-509X.48603
  7. Rhodes A, Jasani B, Balaton AJ, Barnes DM, Miller KD (2000). Frequency of oestrogen and progesterone receptor positivity by immunohistochemical analysis in 7016 breast carcinomas: Correlation with patient age, assay sensitivity, threshold value, and mammographic screening. J Clin Pathol, 53, 688-96. https://doi.org/10.1136/jcp.53.9.688
  8. Rao C, Shetty J, Kishan Prasad HL (2013). Morphological profile and receptor status in breast carcinoma: an institutional study. J Cancer Res Ther. 9, 44-9. https://doi.org/10.4103/0973-1482.110358
  9. Stead LA, Lash TL, Sobieraj JE, et al (2009). Triple-negative breast cancers are increased in black women regardless of age or body mass index. Breast Cancer Res, 11, 18.
  10. Shet T, Agrawal A, Nadkarni M, et al (2009). Hormone receptors over the last 8 years in a cancer referral center in India: What was and what is? Indian J Pathol Microbiol, 52, 171-4. https://doi.org/10.4103/0377-4929.48909
  11. Sandhu DS, Sandhu S, Karwasra RK, Marwah S (2010). Profile of breast cancer at a tertiary care hospital in north India. Indian J Cancer, 47, 16‑22. https://doi.org/10.4103/0019-509X.58853
  12. Sin ghai R, Patil VW, Patil AV (2011). Status of HER-2/neu receptors and Ki-67 in breast cancer of Indian women. Int J App Basic Med Res, 1, 15-9. https://doi.org/10.4103/2229-516X.81974
  13. Sofi GN, Sofi JN, Nadeem R, et al (2012). Estrogen receptor and progesterone receptor status in breast cancer in relation to age, histological grade, size of lesion and lymph node involvement. Asian Pac J Cancer Prev. 13, 5047-52. https://doi.org/10.7314/APJCP.2012.13.10.5047
  14. Sedighi A, Hamed EA, Mohammadian K, Behnood S, Kalaghchi B (2013). Clinicopathologic characteristics of male breast cancer: a report of 21 cases in radiotherapy center of hamedan, iran. Asian Pac J Cancer Prev, 14, 7381-3. https://doi.org/10.7314/APJCP.2013.14.12.7381
  15. Siegel R, Ma J, Zou Z, Jemal A (2014). Cancer statistics 2014. CA Cancer J Clin, 64, 9-29. https://doi.org/10.3322/caac.21208
  16. Taucher S, Rudas M, Mader RM, et al (2003). Do we need HER-2/neu testing for all patients with primary breast carcinoma? Cancer, 98, 2547-53. https://doi.org/10.1002/cncr.11828
  17. Zhou XL, Fan W, Yang G, Yu MX (2014). The clinical significance of PR, ER, NF-$\kappa$B, and TNF-$\alpha$ in breast cancer. Dis Markers, 2014, 494581.
  18. Zubeda S, Kaipa PR, Shaik NA, et al (2014). HER2/neu status: A neglected marker of prognostication and management of breast cancer patients in India. Asian Pac J Cancer Prev. 14, 2231-5. https://doi.org/10.7314/APJCP.2013.14.4.2231